ASK REDCHAT ANYTHING ABOUT AURA BIOSCIENCES, INC.
Aura Biosciences, Inc. (NASDAQ: AURA)
Listen to this Section
$6.99
+0.1650
(
+2.42% )
139.8K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Belzupacap Sarotalocan (Bel-sar)DetailsPrimary Choroidal Melanoma |
Phase 3 |
| Belzupacap Sarotalocan (Bel-sar) (Suprachoroidal (SC) Administration)DetailsPrimary Choroidal Melanoma |
Phase 2 |
| Belzupacap Sarotalocan (Bel-sar)DetailsNon-muscle invasive bladder cancer, Muscle-invasive bladder cancer |
Phase 1 |
Market Data
|
| Open |
$6.99 |
| Previous Close |
$6.82 |
| Volume |
139.8K |
| Market Cap |
$705.44M |
| Day Range |
$6.74 - $7.00 |
| 52 Week Range |
$4.73 - $9.54 |
| Shares Outstanding |
103.44M |
| Change % |
+2.42% |
| Net Change |
▲ 0.1650 |
| Insider Ownership |
-0.01% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Year | 2021 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
1,151,132.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-01-24 |
Sale |
-6609.00 |
Feder Julie B |
| 2023-11-09 |
Buy |
76000.00 |
Johnson David Michael |
| 2023-11-09 |
Buy |
1560000.00 |
Matrix Capital Management Company, LP |
| 2023-11-07 |
Sale |
-3800.00 |
de los Pinos Elisabet |
| 2023-11-07 |
Sale |
-3900.00 |
Feder Julie B |
| 2023-11-03 |
Sale |
-135000.00 |
Hopkins Janet Jill |
| 2023-11-01 |
Sale |
-3385.00 |
Feder Julie B |
| 2023-11-01 |
Sale |
-9586.00 |
de los Pinos Elisabet |
| 2023-10-05 |
Buy |
13500.00 |
Johnson David Michael |